Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-05-19
1997-04-08
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 99, 544105, 544343, 5142305, C07D51316, C07D49800, A61K 31495, A61K 31535
Patent
active
056188153
ABSTRACT:
The present invention relates to 1,9-bridged thiazolo[3,2-a]quinoline derivatives of the general formula (I) ##STR1## in which the substituents Z, X, R.sup.1 have the meaning given in the description, to processes for their preparation and to their use in antibacterial compositions.
REFERENCES:
patent: 4808584 (1989-02-01), Taguchi et al.
patent: 4971967 (1990-11-01), Kondo et al.
patent: 5166203 (1992-11-01), Kondo et al.
patent: 5411960 (1995-02-01), Schwenner et al.
patent: 5468742 (1995-11-01), Petersen et al.
Med. Chem. 1993,36,2621-2626.
Eur. J. Med. Chem. (1991) 26,889-906.
Derwent Abstract of JP 03-190,883, Aug. 20, 1991.
Derwent Abstract of JP 04-120,081, (Apr. 21, 1992).
Y. Inoue, et al., J. Med. Chem., vol. 37, pp. 586-592, (1994).
Y. Jinbo, et al., J. Med. Chem., vol. 37, pp. 2791-2796, (1994).
Y. Jinbo, et al., J. Med. Chem., vol. 36, pp. 2621-2626, (1993).
Bremm Klaus D.
Endermann Rainer
Hallenbach Werner
Himmler Thomas
Jaetsch Thomas
Bayer Aktiengesellschaft
Coleman Brenda
Tsang Cecilia
LandOfFree
1,9-bridged thiazolo[3,2-a]quinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,9-bridged thiazolo[3,2-a]quinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,9-bridged thiazolo[3,2-a]quinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397855